Publication date: Feb 14, 2025
Many conditions, including rheumatologic conditions, preexisted COVID and are not uniquely attributable to prior SARS-CoV-2 infection. If that person walks in the door with a new diagnosis, how do we apply these criteria to those patients? Does every person with new-onset diabetes have long COVID because they had COVID? Although we have raised important concerns, we admit that we do not have the answers to these important questions. However, the committee, as with all National Academies committees, concluded its work with the release of its report. You don’t really have to prove that you have COVID, and then a disease arises at some timepoint. It doesn’t say 30 days or 30 months or 30 yearsIt arises at some point in time.
| Concepts | Keywords |
|---|---|
| Boston | Autoimmune |
| Coronavirus | Calabrese |
| Professor | Clinical |
| Rheumatologic | Committee |
| Concerns | |
| Covid | |
| Definition | |
| Diagnosis | |
| Diseases | |
| Including | |
| Infection | |
| Long | |
| Nasem | |
| Rheumatology | |
| Sars |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | p-Phenylenediamine |
| drug | DRUGBANK | Antithymocyte immunoglobulin (rabbit) |
| pathway | REACTOME | Release |
| disease | IDO | history |
| disease | MESH | etiology |
| drug | DRUGBANK | Isoxaflutole |
| disease | MESH | asymptomatic infections |
| pathway | KEGG | Rheumatoid arthritis |
| disease | MESH | rheumatoid arthritis |
| disease | MESH | myalgic encephalomyelitis |
| disease | MESH | autoimmune diseases |
| disease | MESH | postural orthostatic tachycardia syndrome |
| disease | MESH | shortness of breath |
| pathway | REACTOME | SARS-CoV-2 Infection |
| disease | MESH | SARS-CoV-2 infection |
| disease | MESH | chronic condition |
| disease | MESH | infectious diseases |
| disease | MESH | Arthritis |
| disease | MESH | infection |
| disease | MESH | rheumatic diseases |
| disease | MESH | Long COVID |